As there continues to be an increase in biologic and biosimilar product applications and approvals, new lawsuits and judicial decisions area also on the rise. This webinar will provide updates and trends in biologic and biosimilar litigation, including lawsuits by biosimilar applicants against biologic sponsors, lawsuits between biologic sponsors, and lawsuits between biosimilar manufacturers. Speakers will also discuss recent case law related to patent term exclusivity, United States Patent and Trademark Office (USPTO) proceedings, and important recent and pending Courts of Appeal decisions.


Chad A. Landmon, Partner, Axinn, Veltrop & Harkrider LLP
Christopher M. Mikson, Partner, DLA Piper LLP (US)
Teresa (Terry) Stanek Rea, Partner, Crowell & Moring LLP
Moderated by Neil Di Spirito, Partner, Epstein Becker & Green, PC



  • +$100 for non-members

Webinar & Recording

  • +$100 for non-members
Register Now

Internet Explorer and Microsoft Edge are not supported by the checkout process.

Please use Chrome, Firefox, or Safari.  If you are unable to use these browsers, please contact us at 202-371-1420 or [email protected].org and we will assist you.

An access link will be provided to attendees via email upon registration.

If you are registering on behalf of someone else, the link to access the webinar will go to the email address provided at the point of registration.

Those registering on the day of the webinar will receive an access link via email upon successful payment.

We use Zoom to conduct webinars which works on most devices. You may participate in the webinar on a mobile device via the Zoom App or by dialing in. If you require the dial in information, please contact Coleen Carney at [email protected].

Test your device: https://support.zoom.us/hc/en-us/articles/201362193-Joining-a-meeting

Webinar recordings are sent via email as soon as we are able to process and verify the quality of the recording. This usually occurs within 3 business days of a webinar broadcast.

If multiple people at your organization wish to participate from separate devices, each will be required to purchase access.